Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13G for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN).
- Disclosed ownership: 5.3%.
- Date of event: 30 Sep 2025.
ORBIMED ADVISORS LLC - 30 Sep 2025 SCHEDULE 13G Report for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED CAPITAL LLC
- Symbol
- VTGN
- Shares outstanding
- 30,705,993 shares
- Disclosed Ownership
- 1,639,700 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 18:04:51 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 5.3% ownership in Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 18:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 4.6% | 1,420,300 | 0 | 1,420,300 | /s/ Carl L. Gordon | Carl L. Gordon/Member | |
| ORBIMED CAPITAL LLC | 5.3% | 1,639,700 | 1,639,700 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member |